高血管生成素-2水平与风湿性多肌痛患者动脉炎症及长期糖皮质激素需求相关
这项前瞻性研究纳入39例未经治疗的PMR患者(其中10例经PET-CT证实合并大血管GCA),比较急性期标志物与血管生成标志物的诊断和预后价值。结果显示血管生成素-2在区分PMR是否合并GCA方面优于ESR和CRP(AUC 0.90),且高水平血管生成素-2与长期糖皮质激素需求相关。
要点
- 血管生成素-2鉴别PMR合并GCA的AUC为0.90,敏感度100%、特异度76%。
- 血管生成素-2、ESR和可溶性Tie-2在PMR/GCA重叠患者中显著高于单纯PMR患者。
- 高血管生成素-2水平与单纯PMR患者长期糖皮质激素需求相关。
核心结论
- 基线血管生成素-2评估可能有助于诊断PMR合并的血管炎。
- 高血管生成素-2水平与单纯PMR患者的不良病程相关。
- 血管生成素-2是PMR中有前景的诊断和预后生物标志物。
研究设计与样本
- 前瞻性纳入39例未经治疗的PMR患者,其中10例经PET-CT显示大血管GCA证据。
- 纳入年龄匹配的健康对照32例和感染对照13例进行比较。
- 血清标志物采用ELISA或Luminex法检测,用ROC和Kaplan-Meier分析评估诊断和预后准确性。
主要发现
- 除血管生成素-1外,所有急性期和血管生成标志物在单纯PMR患者中均高于健康对照。
- 血管生成素-2、ESR和可溶性Tie-2在PMR/GCA重叠患者中显著高于单纯PMR患者。
- 血管生成素-2(而非可溶性Tie-2)在区分是否合并GCA方面优于ESR和CRP,AUC为0.90,敏感度100%,特异度76%。
- 高血管生成素-2水平与长期糖皮质激素需求相关。
关键数值与推荐
- 血管生成素-2鉴别PMR合并GCA的AUC为0.90,敏感度100%,特异度76%。
临床怎么用
- 基线检测血管生成素-2可能辅助识别PMR患者中合并的大血管血管炎。
- 高血管生成素-2水平提示单纯PMR患者可能需要长期糖皮质激素治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: PMR frequently co-occurs with GCA. So far, a simple biomarker for detecting concomitant arterial inflammation in PMR patients is lacking. Furthermore, biomarkers predicting disease course in PMR are awaited. We here investigated the diagnostic and prognostic value of acute-phase markers (ESR, CRP, IL-6, serum amyloid A) and angiogenesis markers (VEGF, soluble Tie2, angiopoietin-1, angiopoietin-2) in isolated PMR and PMR/GCA overlap patients. METHODS: We prospectively included 39 treatment-naïve PMR patients, of whom 10 patients also showed evidence of large vessel GCA by PET-CT. Age-matched healthy controls (n = 32) and infection controls (n = 13) were included for comparison. Serum marker levels were measured by an ELISA or Luminex assay. Receiver operating characteristic and Kaplan-Meier analyses were used to asses diagnostic and prognostic accuracy, respectively. RESULTS: All acute-phase and angiogenesis markers, except angiopoietin-1, were higher in isolated PMR patients than in healthy controls. Angiopoietin-2, ESR and soluble Tie-2 were significantly higher in patients with PMR/GCA overlap than in isolated PMR patients. Angiopoeietin-2, but not soluble Tie2, outperformed ESR and CRP in discriminating patients with and without overlapping GCA (area under the curve: 0.90; sensitivity: 100%; specificity: 76%). Moreover, high angiopoietin-2 levels were associated with long-term glucocorticoid requirement. CONCLUSION: Assessment of angiopoietin-2 at baseline may assist diagnosis of concomitant vasculitis in PMR. Moreover, high levels of angiopoietin-2 were associated with an unfavourable disease course in isolated PMR patients. These findings imply that angiopoietin-2 is an interesting diagnostic and prognostic biomarker in PMR.
引用
- van Sleen Y, Boots AMH, Abdulahad WH, et al. High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica. Rheumatology (Oxford). 2020. PMID: 31292652. doi:10.1093/rheumatology/kez261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。